Pharmacokinetics of sufentanil in patients undergoing renal transplantation

Roily G, Kay B, Cockx F. A double-blind comparison of high doses of fentanyl and sufentanil in man. Acta Anacsthesiol Belg 1979; 30: 246–7.

Bovili JG, Sebel PS, Blackburn CL, Oei-Lim V, Heykants JJ. The pharmacokinetics of sufentanil in surgical patients. Anesthesiology 1984; 61: 502–6.

Sjoholm I,Kober A,Odar-Cederlof I,Borja O. Protein binding of drugs in uremic and normal serum. The role of endogenous binding inhibitors, Biochem Pharmacol 1976; 1205–13.

Piafsky KM. Disease-induced changes in the plasma binding of basic drugs. Clin Pharmacokinct 1980; 5: 246–62.

Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker Inc., 1982.

Boxenbaum HG, Riegelman S, Elashoff RM. Statistics estimations in pharmacokinetics. J Pharmacokin Biopharm 1974; 2: 123–48.

Matteo RS, Ornstein E, Young WL, Schwartz AE, Port M, Chang WJ. Pharmacokinetics of sufentanil in the elderly. Anesth Analg 1986; 65: S94.

Gregoretti S, Vinik HR. Sufentanil pharmacokinetics in burn patients undergoing skin grafting. Anesth Analg 1986; 65: S64.

Olsen GG, Benett WM, Porter GA. Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Clin Pharmacol Ther 1975; 17: 677–84.

Piafsky KM. Disease-induced changes in the plasma binding of basic drugs. Clin Pharmacokinct1 1980; 5: 246–62.

Boobis SW. Alteration of plasma albumin in relation to decreased drug binding in uremia. Clin Pharmacol Ther 1977; 22: 147–53.

Lunde PKM, Rave A, Yaffe SJ, Lunde L, Sjoquist F. Plasma protein binding of diphenylhydantoin in man. Clin Pharmacol Ther 1970: 11: 846–55.

Shoeman DW, Benjamin DW, Azasnoff DL. The alteration of plasma proteins in uremia as reflected in the ability to bind diphenylhydantoin. Ann NY Acad Sci 1973; 226: 127–30.